Innovation Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Innovation Pharmaceuticals generated cash of -$2,106,000, which is more than the previous year. Cash used in financing activities reached the amount of -$123,000 last year. Net change in cash is therefore -$2,289,000.
Cash Flow
| 2014 | -7.51M | -2.65M | 12.19M |
|---|---|---|---|
| 2015 | -13.07M | -459K | 16.95M |
| 2016 | -9.88M | -414K | 8.20M |
| 2017 | -11.71M | -336K | 9.87M |
| 2018 | -13.27M | -104K | 11.66M |
| 2019 | -6.33M | -46K | 4.53M |
| 2020 | -4.15M | -91K | 9.68M |
| 2021 | -9.49M | -72K | 13.74M |
| 2022 | -6.28M | -4.08M | 3.97M |
| 2023 | -2.10M | -60K | -123K |
IPIX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.80M | 10.19M | 6.01M | 579K | 2.42M | 4.14M | 6.31M | 8.41M | 4.98M | 2.95M |
Operating activities | ||||||||||
Net income | -3.16M | -7.04M | -13.87M | -6.64M | -8.68M | -16.36M | -15.53M | -12.85M | -13.14M | -8.24M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 373K | 382K | 378K | 373K | 371K | 413K | 405K | 420K | 404K | 289K |
Stock-based compensation expense | 207K | 583K | 183K | 427K | 1.07M | 0 | 1.36M | 713K | 400K | 548K |
| Deferred income tax benefit | 207K | 583K | 183K | 427K | 1.07M | 0 | 1.36M | 713K | 400K | 548K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 418K | 4K | 520K | -84K | -1.05M | -1.51M | 1.17M | 1.69M | -826K | 815K |
Cash generated by operating activities | -2.10M | -6.28M | -9.49M | -4.15M | -6.33M | -13.27M | -11.71M | -9.88M | -13.07M | -7.51M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -60K | -80K | -72K | -91K | -86K | -117K | -336K | -414K | -459K | -2.67M |
Acquisitions Net | 0 | -4M | 0 | 0 | 40K | 13K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -60K | -4.08M | -72K | -91K | -46K | -104K | -336K | -414K | -459K | -2.65M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 5.00M | 9.62M | 9.74M | 0 | 11.83M | 10.09M | 8.17M | 16.09M | 9.77M |
Payments for dividends | -86K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -670K | -55K | -91K | -172K | -220K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.88M | -79K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -123K | 3.97M | 13.74M | 9.68M | 4.53M | 11.66M | 9.87M | 8.20M | 16.95M | 12.19M |
Net Change In Cash | -2.28M | -6.38M | 4.17M | 5.43M | -1.84M | -1.71M | -2.16M | -2.1M | 3.42M | 2.03M |
Cash at end of period | 1.51M | 3.80M | 10.19M | 6.01M | 579K | 2.42M | 4.14M | 6.31M | 8.41M | 4.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |